Glenmark Pharma Gains 1.5% on US FDA Nod for Olopatadine – Equitypandit
March 21, 2025March 21, 2025 Shares of Glenmark Pharmaceuticals Ltd surged 1.5% to touch a day’s high of Rs 1,509 on 21st March after the firm announced that its subsidiary, Glenmark Pharmaceuticals Inc., USA, has received final approval from the US Food & Drug Administration (USFDA) for its Olopatadine…